AstraZeneca Associate Principal Informatics Scientist reviews

3.9

94% would recommend to a friend

(85 total reviews)
avatar

Pascal Soriot

71% approve of CEO

94% positive business outlook

Associate Principal Informatics Scientist employees have rated AstraZeneca with 3.9 out of 5 stars, based on 85 company reviews on Glassdoor. This indicates that most Associate Principal Informatics Scientist professionals have a good working experience there. AstraZeneca is rated in line with the average (within 1 standard deviation) by Associate Principal Informatics Scientist professionals compared to other employers within the Pharmazeutika & Biotechnologie industry (3.5 stars).

Reviews by job title

85 reviews
4.0
Jan 3, 2020
Recommend
CEO approval
Business Outlook

Pros

Many opportunities and responsibilities Good work life balance Availability to explore areas outside of your experience

Cons

Promotions might be slow as it is a flat structure

4.0
Aug 22, 2019
Recommend
CEO approval
Business Outlook

Pros

Great scientific discussions, great community, carrying colleagues, great health benefits, great food, great vacations. People stay long in the company.

Cons

Slow development with respect to career opportunities. Freshly introduced Salary and bonus system based on 360 review, where your salary is dependent on your colleagues salary and review, with a maximum number of people getting the same grade, tend to have a negative impact on team spirit when time for end term reviews. Great opportunity for alternation of work tasks through secondments.

3.0
May 14, 2019
Recommend
CEO approval
Business Outlook

Pros

Nice people, good US location, excellent facilities

Cons

Below industry average for compensation, cost cutting across the company, consistent worry about US site closures, disjointed relationship with Medimmune that drives a two company model

Viewing 64 - 66 of 85 Reviews

Glassdoor has 10,258 AstraZeneca reviews submitted anonymously by AstraZeneca employees. Read employee reviews and ratings on Glassdoor to decide if AstraZeneca is right for you.